Correlation Between Recursion Pharmaceuticals and BRIXMOR

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Recursion Pharmaceuticals and BRIXMOR at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Recursion Pharmaceuticals and BRIXMOR into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Recursion Pharmaceuticals and BRIXMOR OPERATING PARTNERSHIP, you can compare the effects of market volatilities on Recursion Pharmaceuticals and BRIXMOR and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Recursion Pharmaceuticals with a short position of BRIXMOR. Check out your portfolio center. Please also check ongoing floating volatility patterns of Recursion Pharmaceuticals and BRIXMOR.

Diversification Opportunities for Recursion Pharmaceuticals and BRIXMOR

-0.4
  Correlation Coefficient

Very good diversification

The 3 months correlation between Recursion and BRIXMOR is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Recursion Pharmaceuticals and BRIXMOR OPERATING PARTNERSHIP in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BRIXMOR OPERATING and Recursion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Recursion Pharmaceuticals are associated (or correlated) with BRIXMOR. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BRIXMOR OPERATING has no effect on the direction of Recursion Pharmaceuticals i.e., Recursion Pharmaceuticals and BRIXMOR go up and down completely randomly.

Pair Corralation between Recursion Pharmaceuticals and BRIXMOR

Given the investment horizon of 90 days Recursion Pharmaceuticals is expected to generate 10.86 times more return on investment than BRIXMOR. However, Recursion Pharmaceuticals is 10.86 times more volatile than BRIXMOR OPERATING PARTNERSHIP. It trades about 0.03 of its potential returns per unit of risk. BRIXMOR OPERATING PARTNERSHIP is currently generating about -0.01 per unit of risk. If you would invest  763.00  in Recursion Pharmaceuticals on September 12, 2024 and sell it today you would lose (17.00) from holding Recursion Pharmaceuticals or give up 2.23% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy97.78%
ValuesDaily Returns

Recursion Pharmaceuticals  vs.  BRIXMOR OPERATING PARTNERSHIP

 Performance 
       Timeline  
Recursion Pharmaceuticals 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Recursion Pharmaceuticals are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Recursion Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.
BRIXMOR OPERATING 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BRIXMOR OPERATING PARTNERSHIP has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Bond's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for BRIXMOR OPERATING PARTNERSHIP investors.

Recursion Pharmaceuticals and BRIXMOR Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Recursion Pharmaceuticals and BRIXMOR

The main advantage of trading using opposite Recursion Pharmaceuticals and BRIXMOR positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Recursion Pharmaceuticals position performs unexpectedly, BRIXMOR can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BRIXMOR will offset losses from the drop in BRIXMOR's long position.
The idea behind Recursion Pharmaceuticals and BRIXMOR OPERATING PARTNERSHIP pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.